SEC Tracker
Get the app

Apogee Therapeutics APGE

AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio

Form
8-K
Filed
Importance
Notable
  • Signs a material agreement (1.01)
  • Reports shareholder vote results (5.07)
  • Makes a Regulation FD disclosure (7.01)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Apogee Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Amicus Therapeutics FOLD public float $1.7B, Jun 30, 2025
  2. Apellis Pharmaceuticals APLS public float $1.8B, Jun 30, 2025
  3. Supernus Pharmaceuticals SUPN public float $1.7B, Jun 30, 2025
  4. Indivior Pharmaceuticals INDV public float $1.8B, Jun 30, 2025
  5. Sarepta Therapeutics SRPT public float $1.7B, Jun 30, 2025